Stromal features in carcinomas may provide a relatively consistent means to stratify patients afflicted with solid tumors. Stroma-derived transcriptome signatures can now be used to make predictions about patient survival, suggesting the potential for their clinical application in precision medicine to predict disease progression and emergence of therapeutic resistance. Clin Cancer Res; 19(18); 1–3. ©2013 AACR.
- Received July 3, 2013.
- Accepted July 5, 2013.
- ©2013 American Association for Cancer Research.